Hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer

Tao Wu,Xi-Xia Zhao,Guoqing Wang 대한부인종양학회 2018 Journal of Gynecologic Oncology Vol.29 No.4

.

Analysis of Aerodynamic Characteristics of Rotor Near Water Surface

Fan Yang,Guoqing Zhao,Xi Chen,Qijun Zhao,Chenkai Cao 한국전산유체공학회 2022 한국전산유체공학회 학술대회논문집 Vol.2022 No.10

An improved high-order TENO scheme with optimized hyper-parameter for aeroacoustics source simulations of helicopter rotor

Yang Tao,Zhao Guoqing,Chen Xi,Zhao Qijun 한국전산유체공학회 2022 한국전산유체공학회 학술대회논문집 Vol.2022 No.10

Antiproliferative Activities of Parthenolide and Golden Feverfew Extract Against Three Human Cancer Cell Lines

Changqing Wu,Feng Chen,James W. Rushing,Xi Wang,김현진,George Huang,Vivian Haley-Zitlin,Guoqing He 한국식품영양과학회 2006 Journal of medicinal food Vol.9 No.1

The medicinal herb feverfew [Tanacetum parthenium (L.) Schultz-Bip.] has long been used as a folk remedyfor the treatment of migraine and arthritis. Parthenolide, a sesquiterpene lactone, is considered to be the primary bioactivecompound in feverfew having anti-migraine, anti-tumor, and anti-inflammatory properties. In this study we determined, throughin vitrobioassays, the inhibitory activity of parthenolide and golden feverfew extract against two human breast cancer celllines (Hs605T and MCF-7) and one human cervical cancer cell line (SiHa). Feverfew ethanolic extract inhibited the growthof all three types of cancer cells with a half-effective concentration (EC50) of 1.5 mg/mL against Hs605T, 2.1 mg/mL againstMCF-7, and 0.6 mg/mL against SiHa. Among the tested constituents of feverfew (i.e., parthenolide, camphor, luteolin, andapigenin), parthenolide showed the highest inhibitory effect with an EC50 against Hs605T, MCF-7, and SiHa of 2.6 .g/mL,2.8 .g/mL, and 2.7 .g/mL, respectively. Interactions between parthenolide and flavonoids (apigenin and luteolin) in fever-few extract also were investigated to elucidate possible synergistic or antagonistic effects. The results revealed that apigeninand luteolin might have moderate to weak synergistic effects with parthenolide on the inhibition of cancer cell growth ofHs605T, MCF-7, and SiHa.

Whole transcriptome mapping reveals the lncRNA regulatory network of TFP5 treatment in diabetic nephropathy

Luo Hongyan,Yang Lirong,Zhang Guoqing,Bao Xi,Ma Danna,Li Bo,Cao Li,Cao Shilu,Liu Shunyao,Bao Li,E Jing,Zheng Yali 한국유전학회 2024 Genes & Genomics Vol.46 No.5

Background TFP5 is a Cdk5 inhibitor peptide, which could restore insulin production. However, the role of TFP5 in diabetic nephropathy (DN) is still unclear. Objective This study aims to characterize the transcriptome profiles of mRNA and lncRNA in TFP5-treated DN mice to mine key lncRNAs associated with TFP5 efficacy. Methods We evaluated the role of TFP5 in DN pathology and performed RNA sequencing in C57BL/6J control mice, C57BL/6J db/db model mice, and TFP5 treatment C57BL/6J db/db model mice. The differentially expressed lncRNAs (DElncRNAs) and mRNAs (DEmRNAs) were analyzed. WGCNA was used to screen hub-gene of TFP5 in treatment of DN. Results Our results showed that TFP5 therapy ameliorated renal tubular injury in DN mice. In addition, compared with the control group, the expression profile of lncRNAs in the model group was significantly disordered, while TFP5 alleviated the abnormal expression of lncRNAs. A total of 67 DElncRNAs shared among the three groups, 39 DElncRNAs showed a trend of increasing in the DN group and decreasing after TFP treatment, while the remaining 28 showed the opposite trend. DElncRNAs were enriched in glycosphingolipid biosynthesis signaling pathways, NF-κB signaling pathways, and complement activation signaling pathways. There were 1028 up-regulated and 1117 down-regulated DEmRNAs in the model group compared to control group, and 123 up-regulated and 153 down-regulated DEmRNAs in the TFP5 group compared to the model group. The DEmRNAs were involved in PPAR and MAPK signaling pathway. We confirmed that MSTRG.28304.1 is a key DElncRNA for TFP5 treatment of DN. TFP5 ameliorated DN maybe by inhibiting MSTRG.28304.1 through regulating the insulin resistance and PPAR signaling pathway. The qRT-PCR results confirmed the reliability of the sequencing data through verifying the expression of ENSMUST00000211209, MSTRG.31814.5, MSTRG.28304.1, and MSTRG.45642.14. Conclusion Overall, the present study provides novel insights into molecular mechanisms of TFP5 treatment in DN. Background TFP5 is a Cdk5 inhibitor peptide, which could restore insulin production. However, the role of TFP5 in diabetic nephropathy (DN) is still unclear. Objective This study aims to characterize the transcriptome profiles of mRNA and lncRNA in TFP5-treated DN mice to mine key lncRNAs associated with TFP5 efficacy. Methods We evaluated the role of TFP5 in DN pathology and performed RNA sequencing in C57BL/6J control mice, C57BL/6J db/db model mice, and TFP5 treatment C57BL/6J db/db model mice. The differentially expressed lncRNAs (DElncRNAs) and mRNAs (DEmRNAs) were analyzed. WGCNA was used to screen hub-gene of TFP5 in treatment of DN. Results Our results showed that TFP5 therapy ameliorated renal tubular injury in DN mice. In addition, compared with the control group, the expression profile of lncRNAs in the model group was significantly disordered, while TFP5 alleviated the abnormal expression of lncRNAs. A total of 67 DElncRNAs shared among the three groups, 39 DElncRNAs showed a trend of increasing in the DN group and decreasing after TFP treatment, while the remaining 28 showed the opposite trend. DElncRNAs were enriched in glycosphingolipid biosynthesis signaling pathways, NF-κB signaling pathways, and complement activation signaling pathways. There were 1028 up-regulated and 1117 down-regulated DEmRNAs in the model group compared to control group, and 123 up-regulated and 153 down-regulated DEmRNAs in the TFP5 group compared to the model group. The DEmRNAs were involved in PPAR and MAPK signaling pathway. We confirmed that MSTRG.28304.1 is a key DElncRNA for TFP5 treatment of DN. TFP5 ameliorated DN maybe by inhibiting MSTRG.28304.1 through regulating the insulin resistance and PPAR signaling pathway. The qRT-PCR results confirmed the reliability of the sequencing data through verifying the expression of ENSMUST00000211209, MSTRG.31814.5, MSTRG.28304.1, and MSTRG.45642.14. Conclusion Overall, the present study provides novel insights into molecular mechanisms of TFP5 treatment in DN.

Up-Conversion Nanoparticles/PMMA Composites for Light-Emitting Applications

Yongling Zhang,Peng Lv,Xiang Liu,Haoyuan Chi,Guoqing Xi,Zhengkun Qin 성균관대학교(자연과학캠퍼스) 성균나노과학기술원 2020 NANO Vol.15 No.03

In this paper, we prepared KMnF3:Yb3+, Er3+ nanoparticles (NPs)/polymethyl methacrylate (PMMA) composites, NaYF4:Yb3+, Tm3+NPs/PMMA composites and NaYF4Yb3+, Er3+NPs/PMMA composites by in situ polymerization, and these NPs/PMMA composites can emit red, blue and green up-conversion fluorescence excited by 980nm, respectively. The mixed white NPs/PMMA composites were obtained by adjusting the doping ratio of the above three NPs. These NPs/PMMA composites are transparent. We tested the up-conversion fluorescence spectra of all the NPs and NPs/PMMA composites, under 980 nm excitation. The up-conversion luminescence spectra of the NPs and NPs/PMMA composites are consistent, which further indicates that the in situ polymerization has not changed the chemical structure of the NPs. Then, we prepared transparent bulk polymers by curing these NPs/PMMA composites. Under 980 nm laser excitation, these NPs/PMMA bulk polymers can emit red, blue, green and white up-conversion emissions, respectively. The results indicate that the NPs/PMMA composites can be applied to three-dimensional (3D) display.

Evaluation of the Immunomodulatory and Anti-inflammatory Activities of Honey Bee Larva Powder

Kejuan Li,Shuang Sun,Masakatsu Kageyama,Long Xiao,Guoqing Xing,Ran Gao,Fengming You,Xi Fu,Zhenya Zhang 한국식품영양과학회 2020 Journal of medicinal food Vol.23 No.7

Honey bee larva powder (HLP) has traditionally been used as a daily supplement and tonic for health promotion with an uncertain scientific basis. In this study, B16-F10 tumor-bearing mice were established to evaluate the immunomodulatory activity of HLP. The proliferation and apoptosis assays were performed to evaluate the anti-inflammatory activity of honey bee larva extract (HLE) in RAW 264.7 macrophage. The in vivo experimental results demonstrated that the oral administration of freeze-dried HLP (4 and 6 g/kg) significantly enhanced the spleen index, the percentage of CD4+cells, and the ratio of CD4+ and CD8+ T lymphocytes (CD4+/CD8+) in the peripheral blood compared with those in the tumor control mice. The in vitro studies demonstrated the potent immunomodulatory activities of HLE through the induction of RAW 264.7 macrophage proliferation and the mitigation of doxorubicin (DOX)-induced toxicity. HLE also exhibits anti-inflammatory activity by decreasing the production of nitric oxide (NO) and the cytokine level of interleukin-6 (IL-6) in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophage. The present study provides important scientific evidence for the immunomodulatory and anti-inflammatory activities of HLP and HLE.